What's New!

Genomics Gateway »

[4 May 2009 | No Comment | ]

Hi all,

As one of the first actvities, we are introducing an interview series with innovators, technologists and change makers in the genomics space.

How about naming this ‘On the trail with Genomic Pioneers’?

We did ’sort of’ start this off last year. We can now slowly expand this into webcasts as we go along.

We are also contemplating starting an online live discussion on interesting scientific or business topics in genomics. We will throw some topics up for discussion in a couple of days time. This will be a once a month feature, we could do this on a Saturday every month, so that we can debate and discuss without affecting our weekly schedules. If you could please participate in this quick poll, it will help taking this forward. You can participate in the poll by clicking on either of these links:
http://ocimumbiosolutions.com/thoughtleaders/2009/05/omics-saturdays/
http://answers.polldaddy.com/poll/1591920/

If there is some exciting new work you would like to share or recommend to be featured in the gateway, please do get in touch with me.

more later.

cheers,
Ashwin

————–
Group Coordinator,
Genomic Pioneers Gateway
A Genelogic-Ocimum Biosolutions Initiative
email: ashw...@ocimumbio.com
www.genomicpioneers.com

Meet the Genomic Pioneers »

[7 Oct 2008 | No Comment | ]
Dr. Srikanta Kumar Rath

Dr. Srikanta Kumar Rath, Scientist, Genotoxicity Laboratory, Central Drug Research Institute. Dr Rath has contributed significantly to the field of molecular toxicology and understanding of disease genomics by developing  assays for genotoxicity using oligonucleotides and real-time approaches. He has built a tremendous understanding of SNPs in different DNA repair genes in several subpopulations of India and  an understanding of gene expression profile of Anti malarials. Dr Rath was one of the key implementors in the creation of Indian Genome Variation Consortium database (IGVdb). Dr Rath’s vision is to develop models to understand toxicity and disease effects. Dr Rath is making efforts to study toxicity and human disease parallely and to make the convergence at some point which will be useful in future for diagnosis.

More information…